Clinical Trials
35 trialsFecal Microbial Transplants for the Treatment of Pancreatic Cancer
M.D. Anderson Cancer Center
PHL Treatment in Pancreatic Cancer
Fox Chase Cancer Center
CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
Washington University School of Medicine
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
Rutgers, The State University of New Jersey
AI-PACED
Mayo Clinic
IGNITE
University of Pennsylvania
Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer
Duke University
ACCELERATE
British Columbia Cancer Agency
Escitalopram to Placebo in Patients With Localized Pancreatic Cancer
Case Comprehensive Cancer Center
Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma
Case Comprehensive Cancer Center
DC Vaccine in Pancreatic Cancer
University of Pennsylvania
CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer
Thomas Jefferson University
Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib for Patients With Advanced Pancreatic Cancer
Fudan University
NALIRIFOX as Induction Therapy in LAPC
The First Affiliated Hospital with Nanjing Medical University
CEBOIDS
Sixth Affiliated Hospital, Sun Yat-sen University
Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma
University of Malaya
Should a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma.
Ruijin Hospital
HOPE-1
Second Affiliated Hospital, School of Medicine, Zhejiang University
A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer
University Health Network, Toronto
CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer
University of Washington
Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended?
Ruijin Hospital
EUS-RFA for Unresectable Pancreatic Cancer
First People's Hospital of Hangzhou
Clinical Study Between Robotic and Open Surgery in Patients With Pancreatic Cancer
Ruijin Hospital
A Clinical Study to Evaluated Which Number of Passes of EUS-FNB is Better for Culturing Primary Cells of PDAC
The Third Xiangya Hospital of Central South University
Comparing Total Laparoscopic Versus Open Pancreaticoduodenectomy
Tongji Hospital
MRI Effects of Pegvorhyaluronidase Alfa (PEGPH20) in Pancreatic Ductal Adenocarcinoma
Abramson Cancer Center at Penn Medicine
Endoscopic Ultrasound Radiofrequency Ablation (EUS-RFA) of Not-resectable Pancreatic Cancer
Campus Bio-Medico University
Study of NAC of GA Therapy for Patients With BRPC
Wakayama Medical University
Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial
Yonsei University
Application of Intrahepatic Arterial Infusion Chemotherapy for Patients With High Risk of Liver Metastases After Pancreatic Cancer Surgery
Peking University Third Hospital
Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer
Wakayama Medical University
S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer
National Taiwan University Hospital
A Biomarker Study to Identify Predictive Signatures of Response to LDE225 (Hedgehog Inhibitor) In Patients With Resectable Pancreatic Cancer
University of Utah
Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer
University of Virginia
POUDER
Heidelberg University